brochure 2015v1.3 20160105 - anzdata€¦ · australia and new zealand 2003-2014 censored for...
TRANSCRIPT
2015 Summary ‐ data to 31 December 2014
0
200
400
600
Num
ber o
f tra
nspl
ants
2010 2011 2012 2013 2014
Australia 2010-2014Living and deceased donor transplants
Living donorDeceased donor
0.00
0.25
0.50
0.75
1.00
Gra
ft S
urvi
val
0 5 10 15 20Years
2010-2014 (n=2922)2005-2009 (n=1911)2000-2004 (n=1849)1995-1999 (n=1779)
Australia and New Zealand 1995-2014Primary deceased donor graft survival
Transplant outcomes in Australia and New Zealand are excellent, and ge ng even be er over me. In the above graph, gra failure includes both death and loss of func on.
TRANSPLANTATION
The majority of kidney transplants performed in Australia are from deceased donors. In recent years there has been a large increase in the deceased donor rate. The living donor rate has been rela vely stable over 2010 to 2014 .
2015 Summary ‐ data to 31 December 2014
c/‐ Royal Adelaide Hospital North Terrace Adelaide South Australia Phone: +61 8 8222 0951 Fax: +61 8 8222 0985 Email: [email protected] Website: www.anzdata.org.au
CONTACT US
PUBLICATIONS ANZDATA is the source of a large number of scien fic and other publica ons. Some selected recent publica ons are listed here.
Lawton PD et al. Survival of Indigenous Australians receiving renal replacement therapy: closing the gap? Med J Aust. 2015 Mar 2;202(4):200–4.
Kasza J et al. Clustering and Residual Confounding in the Applica on of Marginal Structural Models: Dialysis Modality, Vascular Access, and Mortality. Am J Epidemiol. 2015 Sep 15;182(6):535–43.
Wyld ML et al. Pregnancy outcomes for kidney transplant recipients with transplanta on as a child. JAMA Pediatr. 2015 Feb 2;169(2):e143626.
Spicer RA et al. Pa ent and Gra Survival Following Kidney Transplanta on in Recipients With Cys nosis: A Cohort Study. Am J Kidney Dis. 2014 Sep 18.
A more complete list is available on our website.
The Australia and New Zealand Dialysis and Transplant Registry (ANZDATA) records the incidence, prevalence and outcomes of dialysis and transplant treatment for pa ents with end‐stage
kidney disease
Data on chronic dialysis and transplanta on Indicators of clinical process
Outcome Data
COLLECTS
Outcome of treatment Individual Hospital ac vity
Australian and New Zealand data
REPORTS
For widespread use of its data for Quality Assurance, Audits, Surveys,
Service Planning and Research Projects
PROVIDES
v2015
2015 Summary ‐ data to 31 December 2014
2015 Summary ‐ data to 31 December 2014
0
100
200
300
400
New
pat
ient
s pe
r mill
ion
popu
latio
n
2005 2006 2007 2008 2009 2010 2011 2012 2013 2014
Australia indigenous New Zealand indigenousAustralia non-indigenous New Zealand non-indigenous
New patients 2005-2014
Australia New Zealand
PD Home HD Other HD
31 December 2014Dialysis modality by country
Australia Total 22,234 (947)
No. Functioning Transplants 10,143 (432)
No. Dialysis Patients 12,091 (515)
Proportion Home Haemodialysis 9.4%
Proportion Facility Haemodialysis 70.1%
Proportion Peritoneal Dialysis 20.4%
New Zealand Total 4,306 (959)
No. Functioning Transplants 1,628 (362)
No. Dialysis Patients 2,678 (596)
Proportion Home Haemodialysis 18.3%
Proportion Facility Haemodialysis 51.1% Proportion Peritoneal Dialysis 30.6%
0.00
0.25
0.50
0.75
1.00
Tech
niqu
e S
urvi
val
0 1 2 3 4 5Years
2012-2014 (n=2912)2009-2011 (n=2531)2006-2008 (n=2780)2003-2005 (n=2455)
Australia and New Zealand 2003-2014Censored for transplant
Technique survival - peritoneal dialysis at 90 days
0
20
40
60
80
100
Per
cent
0 20 40 60Caring hospital
Excludes hospitals with <10 patients
Australia and New Zealand 2014% New HD patients starting with AVF/AVG
New Zealand.
At the end of 2014 there were just over 22,000 pa ents receiving renal replacement therapy in Australia and around 4,300 in NZ.
Australia and New Zealand have a strong focus on home dialysis, with 30% of Australian and 49% of New Zealand dialysis pa ents receiving dialysis at home.
PREVALENT PATIENTS
This brochure provides an introduc on to ANZDATA and includes data collected to the end of 2014, and reported in the 2015 Annual Report. The ANZDATA Registry collects informa on on renal replacement therapy (dialysis and transplanta on) for end‐stage kidney disease in Australia and New Zealand.
Much more informa on can be found at our website, including our Annual Report, data forms and dic onaries, list of publica ons and guidelines for reques ng data.
INTRODUCTION
NEW PATIENTS
There were 2610 pa ents who commenced treatment for end‐stage kidney disease in Australia in 2014, a rate of 111 per million popula on. In New Zealand, the number of new pa ents commencing renal replacement treatment was 547, a rate of 122 per million of popula on.
Rates of treated end‐stage kidney disease are substan ally higher in Indigenous than non‐Indigenous popula ons in both Australia and
DIALYSIS
ANZDATA has been repor ng real‐ me and annual “key process indicators” (KPIs) for haemodialysis (HD) and peritoneal dialysis (PD) since 2011. At present for HD we report the propor on of new pa ents star ng HD with a fistula or gra . There is a large varia on between trea ng hospitals.
A rela vely large propor on of dialysis pa ents in Australia and New Zealand use PD. The main reasons for technique failure are death, infec ve complica ons and inadequate dialysis.
2015 Summary ‐ data to 31 December 2014 2015 Summary ‐ data to 31 December 2014